OR WAIT null SECS
April 19, 2022
In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, interviews Joy Aho, senior product manager at Be The Match BioTherapies, about sourcing autologous and allogeneic cell therapies.
September 03, 2021
The potential for okra gum as a polymer candidate for new oral drug formulations was evaluated.
December 23, 2020
The virtual manufacturer and distributor of specialty materials acquired the NY-based company, adding analytical and manufacturing expertise.
July 16, 2020
The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has issued its final opinion on measures for companies to take that will limit the presence of nitrosamines in human medicines.
April 02, 2020
With ingredients sold to multiple markets, excipient manufacturers must understand the different regulatory requirements for pharma vs. food.
December 21, 2019
A coalition establishes a secure, direct link between a physical tablet and a digital backend for supply chain integrity.
December 18, 2019
The divestment of the pharma and food ingredients business is in line with Ferrer’s new strategy to focus on the core business of branded pharmaceuticals.
December 02, 2019
This article discusses reduced sampling and testing of starting materials or components. Different strategies are presented to reduce the workload at the steps from sampling to release. Viewpoints from the different pharmacopoeias and regulatory authorities, as well as selected literature, are reviewed.
November 20, 2019
A new sucrose product from MilliporeSigma has reduced nanoparticle impurities.
October 01, 2019
High-throughput platforms can be used to develop tertiary phase diagrams, which can be leveraged to identify the most stable SEDDS formulations and excipients for lipid-based drug delivery systems.